Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23–6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates-Reference-Cited by-同舟云学术

Modifications for disk diffusion susceptibility testing criteria of clinafloxacin (CI-960, AM-1091, PD127371) and fleroxacin (Ro 23–6240, AM-833) following studies with a challenge panel of ciprofloxacin-resistant clinical isolates

Published:1995-04 Issue:4 Volume:21 Page:209-213
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Jones Ronald N.,Johnson David M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference15 articles.

1. Antimicrobial activity evaluations of the two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628;Barrett;Diagn Microbiol Infect Dis,1991

2. Ciprofloxacin: a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria;Chin;Antimicrob Agents Chemother,1984

3. In vitro activity of Ro 23–6240, a new fluorinated 4-quinolone;Chin;Antimicrob Agents Chemother,1986

4. In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391;Cohen;Diagn Microbiol Infect Dis,1991

5. RO 23–6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria;Fuchs;Diagn Microbiol Infect Dis,1987

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative activity of clinafloxacin and nine other compounds tested against 2000 contemporary clinical isolates from patients in United States hospitals;Diagnostic Microbiology and Infectious Disease;1999-09

2. In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates;International Journal of Antimicrobial Agents;1999-06

3. Clinafloxacin in Serious Infections Caused by Multiply Resistant Pathogens;Drugs;1999

4. In Vitro Activities of Clinafloxacin against Contemporary Clinical Bacterial Isolates from 10 North American Centers;Antimicrobial Agents and Chemotherapy;1998-05